vincentcouey/pbm-spread-pricing-2026

PBM Spread Pricing & Drug Coverage Cross-Reference 2026

Pre-computed aggregates merging three first-party OmniRx datasets — 53 drug interactions, 55 patient assistance programs, and 50 insurer formulary / drug-coverage records — into a cross-reference for studying pharmacy-benefit-manager (PBM) spread pricing and patient drug-cost exposure.

• License: CC-BY 4.0
• DOI: 10.5281/zenodo.20632743
• Source study: https://omnirx.org/research/pbm-spread-pricing-2026/
• Author: Vincent Wesley Couey (ORCID 0009-0005-6869-308X) · published via OmniRx (omnirx.org), part of the Lattice research network. Editorially reviewed (YMYL).

What's in it

data.json contains: primary_sources (incl. the FTC Interim Staff Report on PBMs), dataset_counts, interactions, patient_assistance_programs, formularies, cross_tabulation, headline_findings, methodology_notes, and data_gaps.

Method (summary)

Aggregates merge three first-party OmniRx datasets against named primary sources (FTC PBM report and others listed in primary_sources). See methodology_notes and data_gaps in the file for scope, limitations, and what is explicitly NOT covered.

Primary sources

Includes the FTC Interim Staff Report on Pharmacy Benefit Managers (Jul 2024) and additional regulatory/clinical sources enumerated in primary_sources.

Medical disclaimer

This dataset is for informational and research use only. It is not medical advice and must not be used to make treatment, dosing, or coverage decisions. Drug interactions, assistance-program terms, and formularies change frequently; verify against the primary source and a licensed professional before relying on any value.

Citation

Couey, V. W. (2026). PBM Spread Pricing & Drug Coverage Cross-Reference 2026 [Data set]. OmniRx. https://doi.org/10.5281/zenodo.20632743

CC-BY 4.0 — free to use with attribution.